Literature DB >> 20421514

Elevated mineralocorticoid receptor activity in aged rat vascular smooth muscle cells promotes a proinflammatory phenotype via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase and epidermal growth factor receptor-dependent pathways.

Alexander W Krug1, Lena Allenhöfer, Robert Monticone, Gaia Spinetti, Michael Gekle, Mingyi Wang, Edward G Lakatta.   

Abstract

Arterial aging is a predominant risk factor for the onset of cardiovascular diseases, such as hypertension, myocardial infarction, or stroke. Aging is associated with intravascular renin-angiotensin system activation, increased vascular stiffness, intima-media thickening, and a proinflammatory phenotype. Little is known about the influence of aldosterone on arterial aging. Hence, we hypothesized that aldosterone and mineralocorticoid receptor (MR) activation might contribute to and possibly accelerate the arterial aging process. We demonstrate increased MR expression in whole aortae and early passage aortic vascular smooth muscle cells from aged (30 months) compared with adult (8 months) F344XBN rats. Sensitivity to aldosterone-induced extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase activity is increased in aged cells. MR blockade and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase inhibition prevent age-associated increases of transforming growth factor-beta, intercellular adhesion molecule 1, and procollagen 1. Aldosterone increases expression of proinflammatory marker proteins, shifting the phenotype of adult vascular smooth muscle cells toward the proinflammatory phenotype of aged rats. Epidermal growth factor receptor expression is increased with age and by aldosterone, and inhibition of epidermal growth factor receptor tyrosine kinase decreases age-associated proinflammatory marker expression. Our data support the hypothesis that increased constitutive MR signaling may promote and amplify age-associated inflammation that accompanies arterial aging through increased angiotensin II-stimulated expression of MR and enhanced sensitivity to aldosterone-mediated extracellular signal-regulated kinase 1/2 activation, likely related to increased epidermal growth factor receptor expression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20421514      PMCID: PMC2883813          DOI: 10.1161/HYPERTENSIONAHA.109.148783

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  54 in total

Review 1.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease.

Authors:  Edward G Lakatta; Daniel Levy
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

Review 2.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease.

Authors:  Edward G Lakatta; Daniel Levy
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690

Review 3.  Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system.

Authors:  Morag J Young; John W Funder
Journal:  J Hypertens       Date:  2002-08       Impact factor: 4.844

Review 4.  Aldosterone and vascular inflammation.

Authors:  Nancy J Brown
Journal:  Hypertension       Date:  2008-01-02       Impact factor: 10.190

5.  Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury.

Authors:  A Fiebeler; F Schmidt; D N Müller; J K Park; R Dechend; M Bieringer; E Shagdarsuren; V Breu; H Haller; F C Luft
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

6.  Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.

Authors:  Masanori Asakura; Masafumi Kitakaze; Seiji Takashima; Yulin Liao; Fuminobu Ishikura; Tsuyoshi Yoshinaka; Hiroshi Ohmoto; Koichi Node; Kohichiro Yoshino; Hiroshi Ishiguro; Hiroshi Asanuma; Shoji Sanada; Yasushi Matsumura; Hiroshi Takeda; Shintaro Beppu; Michihiko Tada; Masatsugu Hori; Shigeki Higashiyama
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

7.  Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone.

Authors:  Patrick Lacolley; Carlos Labat; Alex Pujol; Claude Delcayre; Athanase Benetos; Michel Safar
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

8.  Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.

Authors:  R Rocha; C T Stier; I Kifor; M R Ochoa-Maya; H G Rennke; G H Williams; G K Adler
Journal:  Endocrinology       Date:  2000-10       Impact factor: 4.736

9.  Human epidermal growth factor receptor-1 expression renders Chinese hamster ovary cells sensitive to alternative aldosterone signaling.

Authors:  Alexander W Krug; Claudia Schuster; Birgit Gassner; Ruth Freudinger; Sigrid Mildenberger; Jakob Troppmair; Michael Gekle
Journal:  J Biol Chem       Date:  2002-09-19       Impact factor: 5.157

10.  Milk fat globule protein epidermal growth factor-8: a pivotal relay element within the angiotensin II and monocyte chemoattractant protein-1 signaling cascade mediating vascular smooth muscle cells invasion.

Authors:  Zongming Fu; Mingyi Wang; Marjan Gucek; Jing Zhang; James Wu; Liqun Jiang; Robert E Monticone; Benjamin Khazan; Richard Telljohann; Julie Mattison; Simon Sheng; Robert N Cole; Gaia Spinetti; Gianfranco Pintus; Lijuan Liu; Frank D Kolodgie; Renu Virmani; Harold Spurgeon; Donald K Ingram; Allen D Everett; Edward G Lakatta; Jennifer E Van Eyk
Journal:  Circ Res       Date:  2009-05-14       Impact factor: 17.367

View more
  40 in total

1.  Essential role of ICAM-1 in aldosterone-induced atherosclerosis.

Authors:  Vincenzo Marzolla; Andrea Armani; Caterina Mammi; Mary E Moss; Vittoria Pagliarini; Laura Pontecorvo; Antonella Antelmi; Andrea Fabbri; Giuseppe Rosano; Iris Z Jaffe; Massimiliano Caprio
Journal:  Int J Cardiol       Date:  2017-01-05       Impact factor: 4.164

Review 2.  30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature.

Authors:  Jennifer J DuPont; Iris Z Jaffe
Journal:  J Endocrinol       Date:  2017-07       Impact factor: 4.286

3.  New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects.

Authors:  Ana Paula Davel; Iris Z Jaffe; Rita C Tostes; Frederic Jaisser; Eric J Belin de Chantemèle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-29       Impact factor: 4.733

Review 4.  Inflammation as a mediator of arterial ageing.

Authors:  Daniel W Trott; Paul J Fadel
Journal:  Exp Physiol       Date:  2019-08-08       Impact factor: 2.969

Review 5.  Mineralocorticoid receptors in vascular function and disease.

Authors:  Amy McCurley; Iris Z Jaffe
Journal:  Mol Cell Endocrinol       Date:  2011-06-24       Impact factor: 4.102

Review 6.  Proinflammatory Arterial Stiffness Syndrome: A Signature of Large Arterial Aging.

Authors:  Mingyi Wang; Robert E Monticone; Kimberly R McGraw
Journal:  J Vasc Res       Date:  2018-08-02       Impact factor: 1.934

7.  PKCδ Mediates Mineralocorticoid Receptor Activation by Angiotensin II to Modulate Smooth Muscle Cell Function.

Authors:  Qing Lu; Ana P Davel; Adam P McGraw; Sitara P Rao; Brenna G Newfell; Iris Z Jaffe
Journal:  Endocrinology       Date:  2019-09-01       Impact factor: 4.736

Review 8.  Mechanisms of Vascular Aging.

Authors:  Zoltan Ungvari; Stefano Tarantini; Anthony J Donato; Veronica Galvan; Anna Csiszar
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

9.  Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation.

Authors:  Sophocles Chrissobolis; Grant R Drummond; Frank M Faraci; Christopher G Sobey
Journal:  J Hypertens       Date:  2014-09       Impact factor: 4.844

Review 10.  Proinflammation: the key to arterial aging.

Authors:  Mingyi Wang; Liqun Jiang; Robert E Monticone; Edward G Lakatta
Journal:  Trends Endocrinol Metab       Date:  2013-12-20       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.